Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Cipla Limited (CIPLA.BO)

Compare
1,481.40
+18.25
+(1.25%)
At close: April 15 at 3:48:35 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Umang Vohra B.E., M.B.A. MD, Global CEO & Executive Director 222.1M -- 1971
Dr. Raju Sunil Mistry M.A., Ph.D. President & Global Chief People Officer -- -- 1965
Mr. Pradeep Bhadauria President & Global Chief Scientific Officer -- -- --
Mr. Ashish Adukia Global Chief Financial Officer -- -- --
Mr. Achin Gupta Global Chief Operating Officer -- -- 1976
Mr. Dinesh Ramniranjan Jain Senior VP & Head of Corporate Finance -- -- --
Ms. Sneha Hiranandani B Com Chief Information Officer -- -- --
Ms. Diksha Maheshwari Head of Investor Relations -- -- --
Mr. Rajendra Kumar Chopra Compliance Officer & Company Secretary 15.3M -- --
Ms. Heena Kanal Senior Vice-President of Corporate Communications -- -- --

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai, 400013
India
91 22 2482 6000 https://www.cipla.com
Sector: 
Healthcare
Full Time Employees: 
27,764

Description

Cipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Corporate Governance

Cipla Limited’s ISS Governance QualityScore as of April 1, 2025 is 5. The pillar scores are Audit: 7; Board: 4; Shareholder Rights: 1; Compensation: 8.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

Cipla Limited Earnings Date

Recent Events

August 2, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers